Forskning
Udskriv Udskriv
Switch language
  1. Region Hovedstaden
  2. Tidsskrifter
  3. Cancer Chemotherapy and Pharmacology
Region Hovedstaden - en del af Københavns Universitetshospital

Cancer Chemotherapy and Pharmacology, 0344-5704

Tidsskrift

Seneste publikationer Vis alle (26) »

  1. Udgivet

    An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  2. Udgivet

    Methotrexate polyglutamate levels and co-distributions in childhood acute lymphoblastic leukemia maintenance therapy

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

  3. Udgivet

    A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24

    Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Vis graf over relationer

Cancer Chemotherapy and Pharmacology

CANCER CHEMOTH PHARM, Cancer chemotherapy and pharmacology, Cancer chemotherapy and pharmacology., Medline Abbreviated Title: Cancer Chemother Pharmacol

Titler
  • Cancer Chemotherapy and Pharmacology
ISSN'er
  • 0344-5704
Yderligere søgbare ISSNs (Elektroniske)1432-0843
ForlagSpringer
LandTyskland

Tidsskrift

ID: 44557